Connect
Brinsupri (aka Brensocatib)
FDA approved Brensocatib today. Hooray for us. Let’s hope we have access to it as soon as possible and it gives us some measure of relief. Thank you to all the scientists and doctors and patients!
https://www.multivu.com/insmed/9347351-en-fda-approves-brinsupri-brensocatib
Like
Helpful
HugInterested in more discussions like this? Go to the MAC & Bronchiectasis Support Group.
Connect
@lindabreathless
I read an article stating that some major insurers are scaling back advantage and part D plans fro 2026 and some people might lose their coverage if it is dropped in certain areas of the country. These changes are a response to financial pressures, including changes to government funding and rising healthcare costs. This has led insurance carriers to scale back their offerings in less profitable regions. I wonder if they will also scale back coverage of specialty drugs as well as dropping locations. Probably will.
CHMP Recommends EU Approval of BRINSUPRI™ Good news for our friends in the EU.https://investor.insmed.com/2025-10-17-CHMP-Recommends-EU-Approval-of-BRINSUPRI-TM-brensocatib-for-the-Treatment-of-Non-Cystic-Fibrosis-Bronchiectasis
-
Like -
Helpful -
Hug
4 Reactions@irenea8 The possible problem is even when people and organizations make decisions that they think are good for them and us it 'ain't' necessarily so. That Drug out of pocket amount sounds great to us but it doesn't sound great to those providing the drug plans. As we know the Brinsupri is very costly and one of the factors that makes it hard for us and the drug companies providing the drug plans. What do you think, do you think that is part of it? The why of it as to why they are leaving areas or dropping coverages???
Barbara
Interesting that this drug comes to market at such a high price. Sure, the company negotiated rebates with insurers but those rates are negligible meaning insurance will pay more for the drug than it's worth.